Company / Return on Equity (ROE)
MAIA Biotechnology, Inc. Return on Equity (ROE) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-639.8%
FY2024
5-year range
-639.8% / -137.0%
FY2022-FY2024
Trend
-245.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
MAIA Biotechnology, Inc. reports negative total equity of -639.8% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-639.8% in FY2024.
Declined from -137.0% to -639.8% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on equity (roe) decreased 245.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -11.78 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -639.8% | -245.2% |
| FY2023 | -185.3% | -35.3% |
| FY2022 | -137.0% | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026